G. Larsen

发表

Primary structure, gene organization and polypeptide expression of poliovirus RNA

B. Semler, E. Wimmer, E. Emini, 1981, Nature.

Stable hairpin structure within the 5'-terminal 85 nucleotides of poliovirus RNA

B. Semler, E. Wimmer, G. Larsen, 1981, Journal of virology.

Cleavage sites within the poliovirus capsid protein precursors

B. Semler, E. Wimmer, C. Anderson, 1982, Journal of virology.

Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies

E. Wimmer, E. Emini, G. Larsen, 1982, Journal of virology.

The structure of poliovirus replicative form.

E. Wimmer, A. Dorner, G. Larsen, 1980, Nucleic acids research.

Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells

S. Latt, R. Kaufman, G. Larsen, 1985, Molecular and cellular biology.

Functional effects of asparagine-linked oligosaccharide on natural and variant human tissue-type plasminogen activator.

G. Larsen, D. Collen, L. Hansen, 1988, The Journal of biological chemistry.

P-selectin and E-selectin. Distinct but overlapping leukocyte ligand specificities.

D. Wagner, B. Furie, G. Larsen, 1992, The Journal of biological chemistry.

Soluble P-selectin glycoprotein ligand 1 inhibits ocular inflammation in a murine model of allergy.

C. Foster, G. Larsen, N. Lee, 1999, Investigative ophthalmology & visual science.

Tissue-type plasminogen activator binding to human endothelial cells. Evidence for two distinct binding sites.

D. Cines, K. McCrae, E. Barnathan, 1988, The Journal of biological chemistry.

Thrombolytic therapy with tissue-type plasminogen activator: new modes and novel variant plasminogen activators.

E. Barnathan, G. Larsen, 1991, Current opinion in biotechnology.

The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin.

G. Larsen, M. Nesheim, J. Fredenburgh, 1990, The Journal of biological chemistry.

Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbits.

G. Larsen, D. Collen, J. Stassen, 1988, Blood.

Pharmacokinetic and distribution analysis of variant forms of tissue-type plasminogen activator with prolonged clearance in rat.

G. Larsen, P. Horgan, M. Metzger, 1989, Blood.

Pharmacokinetic and distribution analysis of variant forms of tissue- type plasminogen activator with prolonged clearance in rat

M. Metzger, G. Larsen, Kimberlee Henson, 1989 .

Protein engineering of novel plasminogen activators with increased thrombolytic potency in rabbits relative to activase.

G. Larsen, G. Timony, P. Horgan, 1991, The Journal of biological chemistry.

Expression cloning of a functional glycoprotein ligand for P-selectin

B. Furie, G. Vachino, D. Cumming, 1993, Cell.

Replacement of finger and growth factor domains of tissue plasminogen activator with plasminogen kringle 1. Biochemical and pharmacological characterization of a novel chimera containing a high affinity fibrin-binding domain linked to a heterologous protein.

G. Larsen, G. Morris, T. J. Ahern, 1991, The Journal of biological chemistry.

human tissue-type plasminogen activator in rabbits Pharmacokinetics and thrombolytic properties of deletion mutants of

G. Larsen, D. Collen, J. Stassen, 2011 .

Variants of human tissue-type plasminogen activator. Fibrin binding, fibrinolytic, and fibrinogenolytic characterization of genetic variants lacking the fibronectin finger-like and/or the epidermal growth factor domains.

G. Larsen, Y. Blue, K. Henson, 1988, The Journal of biological chemistry.

Pharmacokinetics and thrombolytic properties of a nonglycosylated mutant of human tissue-type plasminogen activator, lacking the finger and growth factor domains, in dogs with copper coil-induced coronary artery thrombosis.

G. Larsen, D. Collen, P. Cambier, 1988, Journal of cardiovascular pharmacology.

Site-directed mutagenesis in human tissue-plasminogen activator. Distinguishing sites in the amino-terminal region required for full fibrinolytic activity and rapid clearance from the circulation.

G. Larsen, G. Morris, T. J. Ahern, 1990, The Journal of biological chemistry.

Identification of the initiation site of poliovirus polyprotein synthesis

E. Wimmer, C. Anderson, A. Dorner, 1982, Journal of virology.

Coamplification andCoexpression ofHumanTissue-Type Plasminogen Activator andMurine Dihydrofolate Reductase Sequences inChinese Hamster OvaryCells

S. Latt, R. Kaufman, G. Larsen, 1985 .